ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research

February 10, 1978

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

NIH Makes Changes To Area Grants

April 25, 1997

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014